There were 1,123 press releases posted in the last 24 hours and 445,239 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Zafgen's Phase 2b Trial of Beloranib in Severe Obesity Complicated by Type 2 Diabetes Achieves Primary Efficacy Endpoint

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image